Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] - N0000192700
Pharmacologic Class Information
| Pharmacologic Code | N0000192700 |
| Pharmacologic Name | Lymphocyte Function-Associated Antigen-1 Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Lymphocyte Function-Associated Antigen-1 Antagonists
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function-Associated Antigen-1 Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0911 | Xiidra | Non-Proprietary Name: Lifitegrast | Solution/ Drops | Ophthalmic | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 24208-911 | Xiidra | Non-Proprietary Name: Lifitegrast | Solution/ Drops | Ophthalmic | Bausch & Lomb Incorporated | ACTIVE | |
| 59651-450 | Lifitegrast | Non-Proprietary Name: Lifitegrast | For Solution | Ophthalmic | Aurobindo Pharma Limited | ACTIVE |